About Calypte
Calypte is a publicly listed company based in Portland (United States) founded in 1988. Oral dipstick Immunoassay based HIV test products. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Viral. Its competitors include Quantalife, Chembio and Senzo; 2 of its 3 listed competitors have raised funding.
Company details
In vitro diagnostic products for HIV infection and other sexually transmitted or chronic diseases are developed by Calypte Biomedical Corporation, founded in 1988 and based in Portland, United States. The companys operations focus on point-of-care rapid tests and enzyme immunoassay-based incidence assays. These tools support improved diagnosis in clinical and field settings within the biomedical sector.
- Headquarters Portland, United States
- Stage Public
- SectorsHealthcare
- Website calypte.com
- Social LinkedIn
Competitors of Calypte
Calypte has 3 listed competitors in our database, 2 of them funded. They include Quantalife, Chembio and Senzo.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quantalife.com | 2008 | Pleasanton, United States | $28.71M | Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. | ||
| chembio.com | 1986 | Medford, United States | 213 | Proprietary immunoassay platform is utilized for infectious disease diagnostics. | ||
| senzo.com | 2013 | San Francisco, United States | $9.6M | 13 | Point-of-care diagnostic devices for infectious diseases are developed. |
Detailed competitors of Calypte
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Calypte
Websites that share an audience with Calypte (calypte.com).
Websites whose visitors overlap most with Calypte. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cholestech.com | 100% | View details | |||
| dianon.com | 100% | View details | |||
| premierheart.com | 100% | 3.7K | #3,945,080 | View details | |
cancersafe.com | cancersafe.com | 100% | – | ||
qmasystem.com | qmasystem.com | 100% | #5,290,902 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Calypte
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Calypte (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Calypte
Calypte was founded in 1988.
Calypte is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
In vitro diagnostic products for HIV infection and other sexually transmitted or chronic diseases are developed by Calypte Biomedical Corporation, founded in 1988 and based in Portland, United States. The companys operations focus on point-of-care rapid tests and enzyme immunoassay-based incidence assays. These tools support improved diagnosis in clinical and field settings within the biomedical sector.
Calypte's top competitors include Chembio, Quantalife and Senzo.